A FIFO worker has revealed he earns $165,000 a year operating bulldozers and diggers on a week-on, week-off roster.

Cloud SIEMs are great until a "noisy neighbor" hogs all the resources. You need a vendor that actually engineers fairness so ...

The end is near for the NCAA Tournament. Less than two weeks remain in the college basketball season and Texas men's basketball is among 16 teams still alive for a national championship. After taking ...

This week, the Vigo County School Corp. has been testing alternative class scheduling at North, South and West Vigo high schools as it studies possible changes in future years. Next month, it will ...

Everyone is entitled to their own opinion. That doesn’t mean everyone’s opinion is always right. Alex Taylor is the assistant editor for WyoSports and covers University of Wyoming athletics. He can be ...

Ohio State has a formidable path to return to the College Football Playoff this year. Its conference schedule released by the Big Ten last month included a demanding slate of games, headline by a trip ...

BARRE — Voters in Barre and Barre Town are already deciding how much to spend on the operation of their shared school district, and when those decisions should be made in the future. Heading into the ...

Now that Super Bowl LX has come and gone and the Seattle Seahawks are world champions, everyone in the NFL is officially looking forward to the offseason. Check out our team-by-team offseason previews ...

MARION, Ill. (WSIL) — Deaconess Illinois and the Marion VA Medical Center have announced a groundbreaking partnership that makes Deaconess Illinois the first hospital system in the state to ...

MARION — Deaconess Illinois has become the first hospital system in the state to partner with the U.S. Department of Veterans Affairs on external provider scheduling, a move officials say will speed ...

Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary sarcoidosis is scheduled for mid-April 2026. SAN DIEGO, Feb. 03, ...

Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary sarcoidosis is scheduled for mid-April 2026. “We look forward to ...